#336USNASDAQ

MNST

Monster Beverage

$44.08USD

Data as of 2026-09-05

Composite Score57.6Strong

≤−99

Margin of safety−202%Expensive

Fair value$14.62

Target$24.83

Loss chance63%Moderate-high

SizeLarge cap

SectorConsumer Staples

Dividend—

TypeCommon stock

Price

Pillar breakdown

0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)

Consumer Staples median (n=76)

Quality
Profit margins & asset efficiency
76
Exceptional
Consumer Staples median (n=76) 47
Value
Price vs fundamentals
8
Poor
Consumer Staples median (n=76) 51
Growth
Revenue & earnings trajectory
80
Exceptional
Consumer Staples median (n=76) 49
Momentum
Recent price strength
63
Strong
Consumer Staples median (n=76) 45
Health
Balance sheet & solvency
71
Exceptional
Consumer Staples median (n=76) 40
Profitability
ROE, ROA, ROIC
80
Exceptional
Consumer Staples median (n=76) 48
Technical
Trend & volatility signals
34
Weak
Consumer Staples median (n=76) 51
Risk
Volatility & drawdown profile
80
Exceptional
Consumer Staples median (n=76) 51

025405570100

Exceptional (70+)Strong (55–70)Average (40–55)Weak (25–40)Poor (<25)

Pillars not shown: Sentiment, ML (Phase 5+).

Risk Summary

2 active

Rank gates

Sloan accruals — top decile[sloan_accruals_top_decile]Within-sector top decile of accruals / assets (Sloan 1996).
Net share issuance — top decile[net_issuance_top_decile]Top-decile net issuance over the trailing year (Pontiff-Woodgate 2008 / Daniel-Titman 2006).

These flags keep the raw composite rank (project Rule 16) but forfeit the entered_top5 badge. Two of them — altman_distress and data_quality_input_corruption — additionally force a cautious recommendation; the others act as Top-5 disqualifiers without dictating the buy/hold/sell label on their own.

Manipulation index

Moderate

20/100

Composite penalty: −2.00 pts (informational; rank uses raw composite)

Driven entirely by the rank-gate flag(s) above — no additional annotate-only components fired.

Rolls up Phase 4.5 earnings-manipulation defenses (Sloan · Beneish · Dechow · REM · restatement · late-filing · earnings- quality time-series) into a single 0-100 risk index. The soft composite penalty (max 10 pts) is informational only — the ranking uses the raw composite score per project Rule 16.

Fair price check

5 different valuation methods each estimate what MNST should be worth, then we compare to today's price.

Heavily overvalued

Models suggest MNST is far above estimated fair value

Today's price

$44.08

Median fair price

$14.62

-67% vs today's price

Of 4 methods:4 say pricey(1 outlier excluded)

P/E multiplesOvervalued
thinks it's expensive — estimates $24.83, about 44% below today
EV/EBITDAOvervalued
thinks it's expensive — estimates $19.67, about 55% below today
P/B multiplesOvervalued
thinks it's expensive — estimates $14.62, about 67% below today
DCF (2-stage)Overvalued
thinks it's expensive — estimates $10.89, about 75% below today
Residual IncomeOutlier
estimate looks unreliable — estimates $6.20 — likely unreliable

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair: $14.62
Margin of safety(vs fair value): < −99%
Max (ex-outliers): $24.83
Tangible BVPS: $3.39

Extreme Residual-Income estimate
Post-split share count adjusted

Median of all applicable methods (current price $44.08). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.

Supporting dataRaw fundamentals & data-quality provenance behind the scores above

Raw fundamentals (SEC EDGAR)

Metric	Value
Market cap	$86.36B
Revenue (TTM)	$9.22B
Net income (TTM)	$2.13B
Operating cash flow (TTM)	$2.24B
CapEx (TTM)	$140.85M
Free cash flow (TTM)CFO − CapEx	$2.10B
Total assets	$11.38B
Total liabilities	N/A
Stockholders' equity	$9.36B
Cash & equivalents	$2.19B
Shares outstanding	1.96B
EPS (basic)	$1.09
EPS (diluted)	$1.09
P/E ratio (TTM)	40.59

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date: 2026-08-07
Latest period end: 2026-07-31
Filing lag: 29 days
Missing metrics: 5(total_liabilities, research_and_development, sga_expense, interest_expense, dividends_paid)